🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
* 1.To compare overall survival after treatment with the test tri-therapy (...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
1999-05
Trial ID
NCT00273546
Treatments Being Tested
Primary Objective: To evaluate the overall response rate (including comple...
Status
Completed
Location
Multiple Locations
Start Date
2014-05
Trial ID
NCT02061631
Treatments Being Tested
Primary Objective: * To confirm the dose of aflibercept in western studies...
Status
Completed
Location
Sanofi-Aventis Investigational Site Number 156001
Start Date
2010-07
Trial ID
NCT01148615
Treatments Being Tested
Primary Objective: To determine the dose limiting toxicity (DLT), the maxi...
Status
Completed
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT01907685
Primary Objective: * To compare the continuation of treatment with docetax...
Status
Completed
Location
Investigational Site Number 004
Start Date
2012-08
Trial ID
NCT01576029
Treatments Being Tested
Primary Objective: \- To compare the 3-year progression free survival (PFS...
Status
Completed
Location
Administrative Office
Start Date
2011-12-30
Trial ID
NCT01515748
The purpose of the study is to compare time to progression and overall surv...
Status
Completed
Location
sanofi-aventis US
Start Date
1998-01
Trial ID
NCT00401323
Treatments Being Tested
The purpose of this study is to evaluate the safety of docetaxel administer...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2005-05
Trial ID
NCT00723086
Treatments Being Tested
Phase II: Primary objective: to select one of the 2 test arms (docetaxel w...
Status
Completed
Location
Multiple Locations
Start Date
1998-10
Trial ID
NCT00290966
Treatments Being Tested
Primary Objective: * To demonstrate the superiority of cabazitaxel plus pr...
Status
Completed
Location
Investigational Site Number 840004
Start Date
2011-05-05
Trial ID
NCT01308567
Treatments Being Tested